2,2'-azobis(2-amidinopropane) has been researched along with Anemia, Hemolytic in 1 studies
2,2'-azobis(2-amidinopropane): water-soluble free-radical initiator
Anemia, Hemolytic: A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).
Excerpt | Relevance | Reference |
---|---|---|
"The extension of hemolysis is variable with erythrocyte samples, but 12." | 5.31 | Hemolysis of human erythrocytes induced by tamoxifen is related to disruption of membrane structure. ( Almeida, LM; Cruz Silva, MM; Custódio, JB; Madeira, VM, 2000) |
"The extension of hemolysis is variable with erythrocyte samples, but 12." | 1.31 | Hemolysis of human erythrocytes induced by tamoxifen is related to disruption of membrane structure. ( Almeida, LM; Cruz Silva, MM; Custódio, JB; Madeira, VM, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cruz Silva, MM | 1 |
Madeira, VM | 1 |
Almeida, LM | 1 |
Custódio, JB | 1 |
1 other study available for 2,2'-azobis(2-amidinopropane) and Anemia, Hemolytic
Article | Year |
---|---|
Hemolysis of human erythrocytes induced by tamoxifen is related to disruption of membrane structure.
Topics: Adult; Amidines; Anemia, Hemolytic; Cells, Cultured; Dose-Response Relationship, Drug; Erythrocyte M | 2000 |